iBio Inc. | Ownership

Companies that own iBio Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Eastern Capital Ltd.
8,457,734
48.49%
2,200,000
2.29%
07/12/2018
The Vanguard Group, Inc.
176,480
1.01%
-4,465
0%
06/30/2018
SignatureFD LLC
152,910
0.88%
137,619
0.01%
06/30/2018
Geode Capital Management LLC
34,266
0.2%
-1
0%
06/30/2018
BlackRock Fund Advisors
16,205
0.09%
314
0%
06/30/2018
Northern Trust Investments, Inc.
14,328
0.08%
7,430
0%
06/30/2018
HighTower Advisors LLC
13,502
0.08%
0
0%
06/30/2018
PanAgora Asset Management, Inc.
13,380
0.08%
12,700
0%
06/30/2018
UBS Financial Services, Inc.
8,645
0.05%
-1
0%
06/30/2018
Vanguard Fiduciary Trust Co.
2,960
0.02%
0
0%
06/30/2018

About iBio

View Profile
Address
600 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.ibioinc.com
Updated 07/08/2019
iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals.